Gupta Subash, Taneja Sunil
Department of Surgical Gastroenterology & Liver Transplantation, Centre for Liver & Biliary Surgery, Indraprastha Apollo Hospital, New Delhi 110076, India.
Department of Gastroenterology and Hepatology, Centre for Liver & Biliary Surgery, Indraprastha Apollo Hospital, New Delhi 110076, India.
J Clin Exp Hepatol. 2014 Feb;4(Suppl 1):S85-7. doi: 10.1016/j.jceh.2014.01.001. Epub 2014 Jan 17.
Portal cavernoma cholangiopathy (PCC) is a difficult clinical problem, where the portal cavernoma is both the cause of biliary obstruction and the obstacle to its safe surgical treatment. The available endoscopic and surgical treatment is successful in majority and further intervention is seldom required since the native liver is normal. PCC is not an accepted indication for liver transplantation as only a small proportion of patients will fail both endoscopic and surgical treatment and progressive liver failure is rarely seen. Secondary biliary cirrhosis as a result of long standing biliary obstruction is an accepted indication however establishing a portal inflow in these patients is often difficult and challenging. The deceased donor liver transplantation would always be preferable over living donor liver transplantation as PCC is usually a non-emergency transplant and the graft can have portal blood inflow through a conduit to even a small segment of patent portal venous system or even to a cavernoma vessel.
门静脉海绵样变性胆管病(PCC)是一个棘手的临床问题,门静脉海绵样变性既是胆管梗阻的原因,也是其安全手术治疗的障碍。多数情况下,现有的内镜和手术治疗是成功的,由于肝脏本身正常,很少需要进一步干预。PCC并非肝移植的公认适应证,因为只有一小部分患者内镜和手术治疗均失败,且很少见到进行性肝衰竭。长期胆管梗阻导致的继发性胆汁性肝硬化是公认的适应证,然而在这些患者中建立门静脉血流通常困难且具有挑战性。由于PCC通常不是急诊移植,且移植物可通过导管获得门静脉血流,甚至进入一小段通畅的门静脉系统或甚至进入海绵样变性血管,因此尸体供肝肝移植总是优于活体供肝肝移植。